Sunday, December 10, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Cancer

Biomarker may predict endometrial cancer recurrences

May 18, 2016
in Cancer
0
Share on FacebookShare on Twitter

Endometrial cancer is the most common gynecologic cancer in the U.S. Most cases are diagnosed at early stage and have good prognosis. Unfortunately, some patients with early stage and low grade endometrial cancer experience recurrence – and the reasons are not entirely clear. When recurrence happens, the cancer is often resistant to chemotherapy and has a high rate of mortality.

New research from the lab of Martina Bazzaro, Ph.D., of the Masonic Cancer Center, University of Minnesota and Department of Obstetrics, Gynecology, and Women's Health, suggests the deubiquitinating enzyme (DUB) USP14 as a promising biomarker for identifying risk of recurrence in endometrial cancer patients. DUBs have been linked to cancer progression, initiation and the resistance of chemotherapy. Thus, the inhibition of certain DUBs have been proposed as a targeted therapy for cancer. However this is the first time where DUBs are used as a cancer biomarker.

"We have discovered that women with high levels of USP14 are seven time more likely to recur than women with low levels of it," says Bazzaro, a medicinal chemist and cancer biologist who leads this investigation and holds a patent for this biomarker. She adds that: "knowing a patient's status with regards to USP14 positivity could make a tremendous difference in terms of how a patients is treated and ultimately save her life".

Bazzaro is currently leading an international effort to validate the findings is a larger cohort of low risk endometrial cancer patients. "Our next step is a clinical trial. Patients with low risk endometrial cancer will be given the diagnostic exam, utilizing USP14 to gauge the levels of the cancer," said Bazzaro. "Those with high amounts – a positive test – will be treated more aggressively than current treatments to help prevent potential recurrence. Knowing more about their individual cancers can help us as clinicians to tailor a care plan specifically for them."

###

Media Contact

Caroline Marin
crmarin@umn.edu
612-624-5680
@UMN_Health

http://www.ahc.umn.edu/

Share25Tweet16Share4ShareSendShare
  • Focus on Fusion

    Rochester’s Laser Lab heads new national inertial fusion energy hub

    69 shares
    Share 28 Tweet 17
  • Wayne State University announces creation of two research centers and institutes that aim to impact the health of Detroiters and beyond

    68 shares
    Share 27 Tweet 17
  • ASH: Targeted oral therapy reduced disease burden and improved symptoms for patients with rare blood disorder

    65 shares
    Share 26 Tweet 16
  • When is an aurora not an aurora?

    65 shares
    Share 26 Tweet 16
  • Doctors discover many patients at UNC’s Inflammatory Bowel Disease Clinic screen positive for malnutrition

    65 shares
    Share 26 Tweet 16
  • Anglia Ruskin named University of the Year 2023

    66 shares
    Share 26 Tweet 17
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Study finds plant nurseries are exacerbating the climate-driven spread of 80% of invasive species

Researchers predict climate change-driven reduction in beneficial plant microbes

New study highlights COVID-19’s adaptive strategy for infection

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 208 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In